Brainstem white matter lesions are areas of tissue damage within the myelinated nerve fibers of the brainstem, which includes the midbrain, pons, and medulla oblongata. These lesions are commonly identified on magnetic resonance imaging (MRI) and can represent a wide range of underlying pathological processes. Their clinical significance varies from incidental findings in older adults to markers of aggressive neurological disease.

What Are Brainstem White Matter Lesions?

White matter consists of nerve fibers coated in myelin, a fatty substance that speeds electrical signaling. When these fibers are injured, MRI scans can show focal areas of abnormal signal, often described as hyperintensities on T2-weighted or FLAIR sequences. Brainstem lesions are particularly important because even small areas of damage can disrupt critical functions such as breathing, swallowing, balance, and eye movement.

The location within the brainstem often provides diagnostic clues. For example, lesions in the pons may affect facial sensation and motor control, while medullary lesions can impact cardiovascular and respiratory regulation.

Common Causes

• Small vessel disease: Chronic hypertension and diabetes can damage tiny penetrating arteries, leading to ischemic white matter lesions. These are often bilateral and associated with other signs of cerebral small vessel disease.
• Multiple sclerosis (MS): An autoimmune demyelinating disease that frequently involves the brainstem. Characteristic lesions may appear in the periventricular regions, cerebellar peduncles, and the floor of the fourth ventricle.
• Neuromyelitis optica spectrum disorder: A distinct autoimmune condition that can cause lesions in the area postrema of the medulla, often presenting with intractable hiccups or nausea.
• Acute disseminated encephalomyelitis: A monophasic inflammatory condition, usually following infection or vaccination, that produces multifocal white matter lesions including the brainstem.
• Vasculitis and connective tissue diseases: Systemic lupus erythematosus, Sjögren's syndrome, and other autoimmune vasculitides can cause brainstem involvement.
• Chronic microvascular ischemia: Age-related changes in penetrating arterioles can produce scattered pontine hyperintensities, often termed "pontine punctuate lesions."
• Infectious and granulomatous diseases: Tuberculosis, neurosyphilis, and neurosarcoidosis may produce brainstem lesions.
• Neoplastic and paraneoplastic processes: Primary brainstem gliomas and metastatic disease can cause space-occupying white matter lesions.

Imaging Features and Classification

Brainstem white matter lesions are typically characterized by their appearance on MRI. Key features include lesion location, number, shape, enhancement pattern, and diffusion characteristics.

The Fazekas scale is commonly used to grade periventricular and deep white matter hyperintensities, but brainstem-specific scoring systems are less standardized. A useful distinction is between focal, round lesions (often demyelinating) and diffuse, confluent lesions (often ischemic).

Magnetic resonance spectroscopy and advanced diffusion imaging can provide additional metabolic and microstructural information. For instance, reduced N-acetylaspartate indicates neuronal loss, while elevated choline suggests active demyelination or inflammation.

Clinical Presentation

Symptoms depend on the precise location of the lesion:

• Midbrain lesions: May cause cranial nerve III or IV palsy, vertical gaze palsy, pupillary abnormalities, or tremor (e.g., Benedikt syndrome).
• Pontine lesions: Can produce facial weakness, sixth nerve palsy, internuclear ophthalmoplegia, hearing loss, or trigeminal symptoms. Larger lesions may lead to locked-in syndrome.
• Medullary lesions: May cause dysphagia, dysarthria, vertigo, nystagmus, hypoglossal nerve dysfunction, or autonomic instability (e.g., Wallenberg syndrome).

However, many brainstem lesions, particularly those due to small vessel disease, are asymptomatic and discovered incidentally during neuroimaging for unrelated indications.

Diagnostic Approach

Evaluation typically starts with a detailed neurological history and examination followed by MRI of the brain with and without contrast. Lumbar puncture may be helpful for evaluating oligoclonal bands in suspected multiple sclerosis or aquaporin-4 antibodies in neuromyelitis optica.

Blood tests for inflammatory markers, antinuclear antibodies, and infectious serologies may be indicated based on clinical context. Angiography or vessel wall imaging can assess for vasculitis when vascular pathology is suspected.

Occasionally, a brainstem biopsy is required when the diagnosis remains unclear despite non-invasive testing, particularly for suspected glioma or rare inflammatory disorders.

Treatment and Prognosis

Management is directed at the underlying cause. Ischemic small vessel disease requires cardiovascular risk factor modification, including blood pressure control, lipid management, smoking cessation, and antiplatelet therapy. Multiple sclerosis is treated with disease-modifying therapies to reduce relapse frequency and slow disability progression. Acute inflammatory demyelinating events may respond to high-dose corticosteroids.

The prognosis is highly variable. Patients with incidental microvascular lesions generally have a favorable outlook, whereas those with progressive demyelinating or neoplastic disease may face significant disability. Early diagnosis and targeted treatment improve outcomes.

Keywords

Brainstem lesions, white matter disease, MRI, multiple sclerosis, small vessel disease, pontine hyperintensity, demyelination, ischemic leukoaraiosis, neuroimaging, neurological disorders.